Benzinga's Top Downgrades

Morgan Stanley downgraded Coach Inc COH from Equal-weight to Underweight. The price target for Coach is set to $32. Coach shares fell 2.58 percent to close at $36.29 on Tuesday.
Exane BNP Paribas downgraded GlaxoSmithKline plc (ADR) GSK from Neutral to Underperform. GlaxoSmithKline shares rose 1.34 percent to $43.08 in pre-market trading.
Analysts at Deutsche Bank downgraded Intersil Corp ISIL from Buy to Hold. Intersil shares fell 0.55 percent to $21.58 in pre-market trading.
JP Morgan downgraded Apigee Corp APIC from Overweight to Neutral. Apigee shares slipped 1.88 percent to close at $17.44 on Tuesday.
Analysts at UBS downgraded HSBC Holdings plc (ADR) HSBC from Buy to Neutral. HSBC shares gained 1.11 percent to $37.37 in pre-market trading.
CLSA downgraded Cognizant Technology Solutions Corp CTSH from Outperform to Underperform. Cognizant Tech shares dropped 2.48 percent to close at $55.00 on Tuesday.
Analysts at Raymond James downgraded Atwood Oceanics, Inc. ATW from Market Perform to Underperform. Atwood Oceanics shares declined 2.50 percent to $7.01 in pre-market trading.
Analysts at Morgan Stanley downgraded Freeport-McMoRan Inc FCX from Equal Weight to Underweight. The price target for Freeport-McMoRan has been lowered from $9 to $7. Freeport-McMoRan shares rose 0.39 percent to $10.19 in pre-market trading.
Exane BNP Paribas downgraded AstraZeneca plc (ADR) AZN from Outperform to Neutral. AstraZeneca shares rose 0.89 percent to $33.03 in pre-market trading.

Market News and Data brought to you by Benzinga APIs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Benzinga's Top Downgrades